Literature DB >> 7527260

Mouse liver NAD(P)H:quinone acceptor oxidoreductase: protein sequence analysis by tandem mass spectrometry, cDNA cloning, expression in Escherichia coli, and enzyme activity analysis.

S Chen1, P E Clarke, P A Martino, P S Deng, C H Yeh, T D Lee, H J Prochaska, P Talalay.   

Abstract

The amino acid sequence of mouse liver NAD(P)H:quinone acceptor oxidoreductase (EC 1.6.99.2) has been determined by tandem mass spectrometry and deduced from the nucleotide sequence of the cDNA encoding for the enzyme. The electrospray mass spectral analyses revealed, as previously reported (Prochaska HJ, Talalay P, 1986, J Biol Chem 261:1372-1378), that the 2 forms--the hydrophilic and hydrophobic forms--of the mouse liver quinone reductase have the same molecular weight. No amino acid sequence differences were found by tandem mass spectral analyses of tryptic peptides of the 2 forms. Moreover, the amino-termini of the mouse enzymes are acetylated as determined by tandem mass spectrometry. Further, only 1 cDNA species encoding for the quinone reductase was found. These results suggest that the 2 forms of the mouse quinone reductase have the same primary sequences, and that any difference between the 2 forms may be attributed to a labile posttranslational modification. Analysis of the mouse quinone reductase cDNA revealed that the enzyme is 273 amino acids long and has a sequence homologous to those of rat and human quinone reductases. In this study, the mouse quinone reductase cDNA was also ligated into a prokaryotic expression plasmid pKK233.2, and the constructed plasmid was used to transform Escherichia coli strain JM109. The E. coli-expressed mouse quinone reductase was purified and characterized. Although mouse quinone reductase has an amino acid sequence similar to those of the rat and human enzymes, the mouse enzyme has a higher NAD(P)H-menadione reductase activity and is less sensitive to flavones and dicoumarol, 2 known inhibitors of the enzyme.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527260      PMCID: PMC2142921          DOI: 10.1002/pro.5560030816

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  27 in total

1.  One-electron-transfer reactions in biochemical systems. V. Difference in the mechanism of quinone reduction by the NADH dehydrogenase and the NAD(P)H dehydrogenase (DT-diaphorase).

Authors:  T Iyanagi; I Yamazaki
Journal:  Biochim Biophys Acta       Date:  1970-09-01

2.  Properties and reaction mechanism of DT diaphorase from rat liver.

Authors:  S Hosoda; W Nakamura; K Hayashi
Journal:  J Biol Chem       Date:  1974-10-25       Impact factor: 5.157

3.  Potential bioreductive alkylating agents. 1. Benzoquinone derivatives.

Authors:  A J Lin; L A Cosby; C W Shansky; A C Sartorelli
Journal:  J Med Chem       Date:  1972-12       Impact factor: 7.446

4.  Studies on the reaction mechanism of DT diaphorase. Action of dead-end inhibitors and effects of phospholipids.

Authors:  P M Hollander; L Ernster
Journal:  Arch Biochem Biophys       Date:  1975-08       Impact factor: 4.013

5.  Human dioxin-inducible cytosolic NAD(P)H:menadione oxidoreductase. cDNA sequence and localization of gene to chromosome 16.

Authors:  A K Jaiswal; O W McBride; M Adesnik; D W Nebert
Journal:  J Biol Chem       Date:  1988-09-25       Impact factor: 5.157

6.  NAD(P)H:menadione oxidoreductase. Novel purification of enzyme cDNA and complete amino acid sequence, and gene regulation.

Authors:  J A Robertson; H C Chen; D W Nebert
Journal:  J Biol Chem       Date:  1986-11-25       Impact factor: 5.157

7.  NAD(P)H dehydrogenase and its role in the vitamin K (2-methyl-3-phytyl-1,4-naphthaquinone)-dependent carboxylation reaction.

Authors:  R Wallin; O Gebhardt; H Prydz
Journal:  Biochem J       Date:  1978-01-01       Impact factor: 3.857

8.  Purification and characterization of two isofunctional forms of NAD(P)H: quinone reductase from mouse liver.

Authors:  H J Prochaska; P Talalay
Journal:  J Biol Chem       Date:  1986-01-25       Impact factor: 5.157

9.  Structure-function relationship of NAD(P)H:quinone reductase: characterization of NH2-terminal blocking group and essential tyrosine and lysine residues.

Authors:  M Haniu; H Yuan; S A Chen; T Iyanagi; T D Lee; J E Shively
Journal:  Biochemistry       Date:  1988-09-06       Impact factor: 3.162

10.  Purification and crystallization of rat liver NAD(P)H:(quinone-acceptor) oxidoreductase by cibacron blue affinity chromatography: identification of a new and potent inhibitor.

Authors:  H J Prochaska
Journal:  Arch Biochem Biophys       Date:  1988-12       Impact factor: 4.013

View more
  2 in total

1.  The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction.

Authors:  R Li; M A Bianchet; P Talalay; L M Amzel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

2.  Structures of recombinant human and mouse NAD(P)H:quinone oxidoreductases: species comparison and structural changes with substrate binding and release.

Authors:  M Faig; M A Bianchet; P Talalay; S Chen; S Winski; D Ross; L M Amzel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.